As of April 15, 2025, Akeso (9926.HK) has a market cap of $9.64 billion USD. According to our data, Akeso is ranked No.1660 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $9.64 B |
37.43%
|
Dec 31, 2024 | $7.02 B |
30.71%
|
Dec 29, 2023 | $5.37 B |
7.91%
|
Dec 30, 2022 | $4.98 B |
26.47%
|
Dec 31, 2021 | $3.93 B |
-10.76%
|
Dec 31, 2020 | $4.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
![]() China
|
![]() Jiangsu Hengrui Medicine
600276.SS
|
$42.08 B |
-0.015 B
|
![]() China
|
![]() Zai Lab
ZLAB
|
$3.33 B |
0.000 M
|
![]() China
|
![]() Mindray
300760.SZ
|
$35.08 B |
-0.414 B
|
![]() China
|
![]() Hualan Biological Engineering
002007.SZ
|
$4.03 B |
-0.086 B
|
![]() China
|
![]() Sino Biopharmaceutical
1177.HK
|
$8.21 B |
-0.369 B
|
![]() China
|
Market Cap | = | 9926.HK Stock Price | * | 9926.HK Shares Outstanding |
= | $10.74 | * | 0.90 B | |
= | $9.64 B |